Healthcare -
Biotechnology - NASDAQ - US
$ 18.37
-0.541 %
$ 1.6 B
Market Cap
-4.06
P/E
TVTX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TVTX - Travere Therapeutics, Inc.
55.8 M
LAST VALUE
55.09%
2 YEAR CAGR
17.86%
5 YEAR CAGR
28.54%
10 YEAR CAGR